The new tool, Perception Studio, merges AI and color psychology together to help users make impactful design decisions IRVINE, Calif., Feb. 15, 2024 /PRNewswire/ — Today, Perception, the design intelligence company, announced the launch of Perception Studio – a new offering to help…
Month: February 2024
NEW YORK, Feb. 15, 2024 /PRNewswire/ — The video game market in US is expected to grow by USD 22.99 billion from 2022 to 2027. In addition, the growth momentum of the market will progress at a CAGR of 11.13% during the forecast period, according to Technavio. The market is experiencing…
NEW YORK, Feb. 15, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Waldencast plc (“Waldencast” or the “Company”) (NASDAQ: WALD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Feb. 15, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (NASDAQ: LFST). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext….
NEW YORK, Feb. 15, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Soho House & Co Inc. f/k/a Membership Collective Group Inc. (“Soho House” or the “Company”) (NYSE: SHCO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com…
NEW YORK, Feb. 15, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Hesai Group (“Hesai” or the “Company”) (NASDAQ: HSAI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
– Priority review designation is based on results from the Phase 3 EV-302 trial, which found enfortumab vedotin plus pembrolizumab significantly extended overall survival and progression free survival compared to platinum-containing chemotherapy- TOKYO, Feb. 15, 2024 /PRNewswire/ –…
NANPING, China, Feb. 15, 2024 /PRNewswire/ — Golden Heaven Group Holdings Ltd. (the “Company” or “Golden Heaven”) (Nasdaq: GDHG), an amusement park operator in China, today announced its financial results for the fiscal year ended September 30, 2023. Ms. Qiong Jin, the CEO and Chairman…
– Innovative universal, off-the-shelf in vivo CAR-T Cell therapy – TOKYO and BOSTON, Feb. 15, 2024 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) and Kelonia Therapeutics (CEO, Founder: Kevin Friedman, Ph.D., “Kelonia”) today announced that…
DUBLIN, Feb. 15, 2024 /PRNewswire/ — The “Paclitaxel Injection Global Market Report 2024” has been added to ResearchAndMarkets.com’s offering. The paclitaxel injection market size has grown rapidly in recent years. It will grow from $5.26 billion in 2023 to $6.02 billion in 2024 at a…